HAYLEY MITCHELL: Open Payments
NPI 1346847860 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 41 payments from 12 companies in 2025. Trend: 2023 $1,083 · 2024 $682 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $270 |
| E.R. Squibb & Sons, L.L.C. | 4 | $196 |
| Janssen Pharmaceuticals, Inc | 4 | $176 |
| Vanda Pharmaceuticals Inc. | 6 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $103 |
| ABBVIE INC. | 5 | $89 |
| Teva Pharmaceuticals USA, Inc. | 2 | $51 |
| Alkermes, Inc. | 2 | $36 |
| Indivior Inc. | 2 | $36 |
| Neurocrine BioSciences, Inc. | 2 | $34 |
Products named: REXULTI, COBENFY, SPRAVATO, HETLIOZ, CAPLYTA, VRAYLAR, UZEDY, SUBLOCADE.
Industry payments across NC — which companies pay providers there.
